Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer

1 publisher first detected 27m ago 3% of 40 Science publishers

Headline as filed by Medical Xpress.

Compare coverage — 1 report

Every publisher that filed on this event, earliest first, with each one's headline, summary, times and how long after the first report they filed.
Publisher	Headline	Summary	Published	Detected	Delay	Source	Status
Medical Xpress	Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer	Researchers have identified a promising new target in the treatment of pancreatic cancer. A new study in The American Journal of Pathology demonstrates that blocking complement factor B (CFB), a pivot	9 Nov, 23:00	9 Nov, 23:15	0m	medicalxpress.com	First

Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.

Reader comments

Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.

Nobody has commented on this story yet.

Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer

Compare coverage — 1 report

Reader comments

Add a comment

Related coverage

An inside look at a molecular switch that triggers inflammation

Tree-rich landscapes help birds and bats nearly double cacao yields in Peru

The ELT can probe ultra-diffuse galaxies and their dark matter mysteries

Did early humans collect keepsakes 500,000 years ago?

Researchers reveal how inhaled nanoplastics trigger lung inflammation

Some regions may already be living in a 1.5°C warmer world